MedTrace Logo

MicroPhage S. Aureus / MSSA / MRSA Blood Culture Beta Trial

NCT00814151 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 712

Last updated 2008-12-24

No results posted yet for this study

Summary

In-vitro identification of S. aureus, methicillin-sensitive S. aureus (MSSA), and methicillin-resistant S. aureus (MRSA) from positive blood cultures by MicroPhage's bacteriophage-based diagnostic platform.

Conditions

Interventions

OTHER

MicroPhage S. aureus / MSSA / MRSA Blood Culture Test (prototype)

In vitro diagnostic: The MicroPhage "Intervention" was to perform the MicroPhage diagnostic test to detect S. aureus in the blood culture sample and determine MSSA or MRSA status at 4 and 5 hours of test incubation. The "Intervention" results were not made available to the patient or their physician.

Sponsors & Collaborators

  • MicroPhage, Inc.

    lead INDUSTRY

Principal Investigators

  • J D Smith, Ph.D. · MicroPhage, Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2008-12-31
Completion
2008-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00814151 on ClinicalTrials.gov